自发性脑出血中脑损伤生物标志物的变化
这项前瞻性观察队列研究纳入36例自发性脑出血患者,于入院及24、48、72小时采血检测S100B和NSE,6个月评估预后。结果显示S100B可早期预测死亡和功能结局,48小时S100B预测死亡敏感度75%、特异度80%,24小时S100B预测功能结局敏感度82.6%、特异度72.7%;NSE与临床特征无明显关系。
要点
- S100B在入院、24小时和48小时可区分脑出血存活者与死亡者。
- 48小时S100B预测死亡最佳,AUC 0.817,敏感度75%、特异度80%,界值0.250 μg/L。
- 24小时S100B预测6个月功能结局最佳,敏感度82.6%、特异度72.7%,界值0.202 μg/L。
核心结论
- S100B蛋白可作为自发性脑出血患者死亡和功能结局的早期预测指标。
- S100B检测可提供临床和影像学之外的额外信息,辅助医生管理患者。
研究设计与样本
- 前瞻性观察队列研究,纳入神经重症监护病房收治的自发性脑出血患者36例。
- 于入院及24小时、48小时、72小时采集血样,事件后6个月评估患者结局。
主要发现
- 死亡率为36%。
- 非存活者在入院、24小时和48小时的S100B值均高于存活者(P < 0.05)。
- 不良结局(改良Rankin量表评分>4)患者在24小时、48小时和72小时的S100B水平高于结局良好(mRS评分≤3)患者。
- 48小时S100B预测死亡的AUC为0.817(P = 0.003),敏感度75%、特异度80%,界值0.250 μg/L。
- 24小时S100B预测6个月功能结局的敏感度82.6%、特异度72.7%,界值0.202 μg/L。
关键数值与推荐
- 48小时S100B预测死亡:AUC 0.817,P = 0.003,敏感度75%,特异度80%,界值0.250 μg/L。
- 24小时S100B预测6个月功能结局:敏感度82.6%,特异度72.7%,界值0.202 μg/L。
- NSE值与临床特征无明显关系。
临床怎么用
- 对自发性脑出血患者可于入院及24、48小时检测S100B,辅助早期风险分层。
- S100B结果应结合临床和影像学发现综合判断,不作为单独决策依据。
局限性
- 样本量较小(36例),结论需更大样本验证。
- NSE与临床特征的关系未明确,未报告NSE的具体数值或统计结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: S100B and neuron-specific enolase (NSE) have been widely studied in diverse neurocritical pathologies, being recognized as the most promising biomarkers for brain injury assessment. However, their role in intracerebral hemorrhage (ICH) has not been widely analyzed. METHODS: This was an observational prospective cohort study of patients with ICH admitted to a neurocritical care unit. Blood samples were collected on admission and at 24 hours, 48 hours, and 72 hours. Patient outcomes were assessed at 6 months after the event. RESULTS: Thirty-six patients with ICH were included in the study. The mortality rate was 36%. Nonsurvivors had higher S100B values than survivors at admission, 24 hours, and 48 hours (P < 0.05). Likewise, S100B levels were higher in patients with poor outcomes (modified Rankin Scale [mRS] score >4) compared with those with good outcome (mRS score ≤3) in the 24-hour, 48-hour, and 72-hour samples. Receiver operating characteristic (ROC) curve analysis showed that S100B at admission, 24 hours, and 48 hours can discriminate between patients who survive and those who die as a consequence of ICH. The 48-hour sample (area under the ROC curve, 0.817; P = 0.003) reached the best values for sensitivity (75%) and specificity (80%); cutoff, 0.250 μg/L. For 6-month functional outcome, S100B protein could differentiate between groups at 24, 48, and 72 hours. The S100B 24-hour sample had the best values for sensitivity (82.6%) and specificity (72.7%), with a cutoff of 0.202 μg/L. We found no clear relationship between NSE values and clinical characteristics. CONCLUSIONS: S100B protein acts as early predictor of mortality and functional outcome in patients with ICH. This biomarker measurement can provide additional information beyond clinical and radiologic findings to guide physicians in the management of these patients.
引用
- Ferrete-Araujo AM, Rodríguez-Rodríguez A, Egea-Guerrero JJ, et al. Brain Injury Biomarker Behavior in Spontaneous Intracerebral Hemorrhage. World Neurosurg. 2019. PMID: 31449996. doi:10.1016/j.wneu.2019.08.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。